November 15, 2022
The Federal Circuit on Tuesday handed a win to Abbvie's Pharmacyclics and Johnson & Johnson's Janssen Biotech by saying a generic version of their blockbuster cancer drug Imbruvica infringes their patents, and that those patents aren't invalid.
October 07, 2022
In a rematch over the leukemia medication Imbruvica, AbbVie's Pharmacyclics LLC and Johnson & Johnson's Janssen Biotech urged the Federal Circuit Friday to uphold a lower court ruling that their four patents related to the blockbuster drug are valid.
September 29, 2022
Two of the largest tobacco companies in the world head to the Federal Circuit to fight over a ban R.J. Reynolds won at the U.S. International Trade Commission that blocked Philip Morris from importing IQOS-branded heated tobacco products into the U.S. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.